Ophelia Applauds the DEA’s Extension on Flexibilities

The DEA’s extension continues access to lifesaving treatment for people struggling with opioid use disorder (OUD) Opioid overdose is the #1 cause of death for Americans under 50. NEW YORK, May 11, 2023 /PRNewswire/ — Opioid addiction treatment provider Ophelia applauds the DEA’s “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” that … Read more